Cost-Effectiveness Analysis of Early Minimally Invasive Removal of Intracerebral Hemorrhage
Stroke · 2025
DOI: 10.1161/strokeaha.124.048493 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2025. Verfasst von Janel Hanmer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Pittsburgh, PA (J.H., J.A., K.J.S.). Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Cerebral Hemorrhage, Minimally Invasive Surgical Procedures, Neurosurgical Procedures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Supratentorial intracerebral hemorrhage (ICH) is common and often devastating. In a randomized controlled trial, ICH evacuation with minimally invasive trans-sulcal parafascicular surgery (MIPS) improved functional outcomes at 180 days compared with medical management (MM), primarily in patients with lobar hemorrhages. The cost-effectiveness of MIPS compared with MM is explored. METHODS: A Markov model compared costs and outcomes using ENRICH trial (Early Minimally Invasive Removal of Intracerebral Hemorrhage) data for MIPS versus MM over the 6-month trial duration. Costs were 2020 US$ and effectiveness was quality-adjusted life years. Monthly model transitions between modified Rankin Scale score health states were estimated from trial data. Costs were obtained from US databases and literature. MIPS device costs were $5705/patient. Primary outcomes were total hospital costs from the hospital perspective and the incremental cost-effectiveness ratio between MIPS and MM (ie, the 6-month cost difference between strategies divided by quality-adjusted life year difference) from the healthcare perspective for patients with lobar ICH. Sensitivity analyses were performed. RESULTS: From the hospital perspective, MIPS costs were $2782 less per patient than MM ($74 252 versus $77 034), with MIPS having decreased the intensive care unit hospital length of stay, non-MIPS neurosurgery, mortality, and rehospitalization. From the healthcare perspective, including hospital and nonhospital costs, MIPS in lobar ICH cost $8850 less and gained 0.068 quality-adjusted life year per patient compared with MM; thus MIPS was dominant (less costly and more effective). Results were robust to individual parameter variation over plausible ranges and, with all parameters varied simultaneously in a probabilistic sensitivity analysis, MIPS was dominant in >93% of 10 000 model iterations and favored in >99% at $100 000/quality-adjusted life year gained (a common US benchmark). CONCLUSIONS: In the ENRICH randomized controlled trial, MIPS cost less and was more effective compared with MM from both hospital and healthcare perspectives for patients with lobar ICH. REGISTRATION: URL: https://clinicaltrials.gov/ ; Unique identifier: NCT02880878.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Pittsburgh, PA (J.H., J.A., K.J.S.).
- Department of Emergency Medicine (A.H., D.W.W.), Emory University School of Medicine, Atlanta, GA.
- Department of Emergency Medicine and Neurology (J.J.R.), Emory University School of Medicine and the Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA.
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis (J.W.A.).
- Department of Neurology (M.F.), Emory University School of Medicine and the Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA.
- Department of Neurosurgery (D.L.B.), Emory University School of Medicine, Atlanta, GA.
ORCID-Profile: Janel Hanmer, Jonathan Arnold, Alex Hall, Jonathan J Ratcliff, Jason W Allen, Daniel L Barrow, Gustavo Pradilla
Zitieren
APA
Hanmer, J., Arnold, J., Hall, A., Ratcliff, J. J., Allen, J. W., Frankel, M., Wright, D. W., Barrow, D. L., Pradilla, G., Smith, K. J., & ENRICH Trial Investigators (2025). Cost-Effectiveness Analysis of Early Minimally Invasive Removal of Intracerebral Hemorrhage. Stroke. https://doi.org/10.1161/strokeaha.124.048493
Vancouver
Hanmer J, Arnold J, Hall A, Ratcliff JJ, Allen JW, Frankel M, et al. Cost-Effectiveness Analysis of Early Minimally Invasive Removal of Intracerebral Hemorrhage. Stroke. 2025. doi:10.1161/strokeaha.124.048493
BibTeX
@article{Hanmer2025,
author = {Hanmer, Janel and Arnold, Jonathan and Hall, Alex and Ratcliff, Jonathan J and Allen, Jason W and Frankel, Michael and Wright, David W and Barrow, Daniel L and Pradilla, Gustavo and Smith, Kenneth J and ENRICH Trial Investigators, ENRICH Trial Investigators},
title = {Cost-Effectiveness Analysis of Early Minimally Invasive Removal of Intracerebral Hemorrhage},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.124.048493}
}
EUVIMED